1. This review brings together the information available to date regar
ding how taxol cytotoxicity and the development of resistance to this
drug is affected by its cellular transport and intra cellular binding.
2. Taxol, a potent anticancer drug first extracted from the bark of t
he Pacific yew tree, is extremely effective in the treatment of a wide
range of malignancies. 3. Unlike other antimitotic drugs, taxol promo
tes the formation of highly stable microtubules that resist depolymeri
zation by specifically binding to the N-terminal region of beta-tubuli
n. Taxol binding alters the conformation of the tubulin subunit, thus
greatly retarding tubulin heterodimer dissociation. 4. Cell division i
s then blocked at the mitotic stage and the cell dies. 5. Besides this
central mechanism, taxol exerts numerous other cellular effects. 6. O
bservations made with taxol resistant murine and human: tumor cells ma
ke it increasingly clear that the cellular transport of taxol and its
microtubule binding activity are important factors in the development
of resistance to this drug. GEN PHARMAC 29;2:167-172, 1997. (C) 1997 E
lsevier Science Inc.